Evidence scouting
We scan peer-reviewed papers and public datasets for your exact biomarker question.
Immunode: evidence-first translational immunology
Decision-grade biomarker evidence, on demand.
We're building an evidence-first way to design biomarker decisions together with translational teams.
Step 1: Paper Research Pack — we find and structure the 20–30 most useful papers for a focused biomarker question in 72 hours.
Every dot is a study. Every shortlist link ties back to shared evidence.
Top candidate
● Study ─ Shared evidence link
What Immunode does at a glance
A single pipeline from raw evidence to decisions.
BIPs combine scouting, scoring, and mapping into one auditable flow your team can use right away.
Signal scoring
We score candidates on strength of evidence, feasibility, and practical readiness.
Decision-ready map
You get a ranked shortlist and an audit trail you can show your team.
Process
How a BIP works
Future: Biomarker Intelligence Packs (BIPs)
Built on the same evidence-first pipeline as our Paper Research Packs.
A clear, auditable journey takes you from question to a decision-ready shortlist. Today's beta exposes the evidence-assembly step as the Paper Research Pack, while full BIPs add structured scoring, ranking, and richer audit trails.
01
You send a question
We frame the biomarker question to match indication, cohort, samples, and endpoints.
02
We assemble the evidence
We run targeted searches across literature and public repositories.
03
We score and rank candidates
We score candidates on evidence strength, feasibility, and cost.
04
You review and refine
We walk your team through the evidence map and iterate with you.
Where BIPs help right now
Real, concrete biomarker decisions
These are planned use cases for full BIPs. Right now, teams can start by using Paper Research Packs to answer individual biomarker questions while we build the full product.
Autoimmune
RA PoC selection
Narrow dozens of candidates to a shortlist with transparent trade-offs for RA PoC.
Autoimmune
SLE panel prioritisation
Compare markers on evidence strength, assay feasibility, and turnaround time for SLE.
Oncology
Oncology signal review
Surface reproducible signals from noisy public omics and flow datasets.
Translational
Flow signature validation
Cross-reference cytometry, RNA, and proteomics evidence in one ranked shortlist.
Strategy
Portfolio decisions
Align stakeholders with auditable evidence narratives before investing in assays.
Translational
Assay planning
Score assay cost, availability, and practical readiness to avoid dead ends.
Why teams use BIPs
Trustworthy, practical, and transparent
BIPs are built for scientists, strategists, and trial teams who need defensible evidence fast.
Auditable, not black-box
Every claim traces to a paper or dataset. Inspect every chain yourself.
Built for real assays
Cost bands, turnaround, and feasibility are baked into the scoring.
Faster than ad-hoc desk research
Each BIP condenses dozens of sources into a 3–7 candidate shortlist.
What’s inside a BIP?
Anatomy of a Biomarker Intelligence Pack
This is the future full BIP we’re building, while today’s Paper Pack beta provides the core evidence scaffold: the shortlisted papers, summary, and evidence table.
Each BIP bundles ranking, evidence, and storytelling so your next decision is well charted.
Ranked candidate list
Score mixBiomarkerTypeDirectionScore
FOXP3 methylationDNAUp9.2
CXCL13 proteinProteomicDown8.5
CD4/CD8 ratioFlowUp7.8
Evidence matrix
Studies × attributesDirectional signalReproducibleAssay readyCostLicensing
Slide-ready summary
Internal decksSlide-ready summary for internal discussions.
Illustrative layout for a future BIP; data shown is example only.
Public Beta
Step 1 · Paper Research Pack (live beta)
The first step in transforming translational immunology is finding the right papers faster—and organising them so decisions are obvious.
What you get in each pack
20–30 high-quality, clearly cited papers for one focused biomarker question in one disease.
A one–two line explanation for each paper: what it shows and why it matters.
A 1-page summary of what looks strong, what looks weak, and what to test first.
A simple evidence table (CSV/Sheet) with disease, population, biomarker, endpoint, effect direction, sample size, and notes.
Beta price: £199 per Paper Research Pack — one disease, one focused question, delivered in 72 hours.
If you don’t find the pack useful for your decision, tell us and we’ll refund.
Paper Pack
Tell us what to scout.
Share the biomarker decision you're working through and we'll assemble a curated reading pack from open sources.